AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 279: H882-H888, 2000;
0363-6135/00 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuda, N.
Right arrow Articles by Sellke, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuda, N.
Right arrow Articles by Sellke, F. W.
Vol. 279, Issue 3, H882-H888, September 2000

Effects of pinacidil on coronary Ca2+-myosin phosphorylation in cold potassium cardioplegia model

Naruto Matsuda1, Kathleen G. Morgan2,3, and Frank W. Sellke1

1 Division of Cardiothoracic Surgery, Department of Surgery, and 2 Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston 02215; and 3 Boston Biomedical Research Institute, Boston, Massachusetts 02114


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The effects of the potassium (K+) channel opener pinacidil (Pin) on the coronary smooth muscle Ca2+-myosin light chain (MLC) phosphorylation pathway under hypothermic K+ cardioplegia were determined by use of an in vitro microvessel model. Rat coronary arterioles (100-260 µm in diameter) were subjected to 60 min of simulated hypothermic (20°C) K+ cardioplegic solutions (K+ = 25 mM). We first characterized the time course of changes in intracellular Ca2+ concentration, MLC phosphorylation, and diameter and observed that the K+ cardioplegia-related vasoconstriction was associated with an activation of the Ca2+-MLC phosphorylation pathway. Supplementation with Pin effectively suppressed the Ca2+ accumulation and MLC phosphorylation in a dose-dependent manner and subsequently maintained a small decrease in vasomotor tone. The ATP-sensitive K+ (KATP)-channel blocker glibenclamide, but not the nitric oxide (NO) synthase inhibitor Nomega -nitro-L-arginine methyl ester, significantly inhibited the effect of Pin. K+ cardioplegia augments the coronary Ca2+-MLC pathway and results in vasoconstriction. Pin effectively prevents the activation of this pathway and maintains adequate vasorelaxation during K+ cardioplegia through a KATP-channel mechanism not coupled with the endothelium-derived NO signaling cascade.

coronary vasoconstriction; vascular smooth muscle; potassium channel


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

COLD POTASSIUM CARDIOPLEGIA (usually a K+ concentration of 15-25 mM), whether crystalloid or blood containing, is the most common means of myocardial preservation and has proved to be an essential component of modern cardiac operations. Although protection of cardiac function and myocardial perfusion has been improved, suboptimal cardiac performance still occurs postoperatively in a small set of patients, especially when operations are performed on acutely ischemic patients. A reason for this myocardial dysfunction may be related to coronary vasoconstriction during or after cardiac operations in which the administration of K+ cardioplegia has been performed (18). Although the pathogenesis of vasospasm is not fully understood, altered vasomotor regulation in coronary smooth muscle associated with prolonged exposure to K+ cardioplegia seems to be one of the essential events in this setting. Recent works have shown that K+ cardioplegia causes a marked change in the coronary smooth muscle intracellular calcium concentration ([Ca2+]i) (8, 23). In addition, it has been reported that enhanced phosphorylation of the myosin light chain (MLC) in vascular smooth muscle could play a central role in the pathogenesis of coronary vasoconstriction (6).

In an effort to improve on the shortcoming of high-K+ cardioplegic solutions, K+ channel openers have received more attention. To date, several studies have demonstrated that supplementation of K+ channel openers improved the cardioprotective effects afforded by K+ cardioplegia (4, 7). One important factor that may contribute to this beneficial phenomenon is possibly related to the K+ channel opener-evoked coronary vasorelaxation. However, there is little information available regarding the molecular and cellular mechanisms, particularly the role of Ca2+, and the sequence of signaling events such as MLC phosphorylation underlying the development of vasoprotection. For this reason, the present study was designed to investigate the effects of supplementation of pinacidil, a widely used K+ channel opener, on the coronary vasomotor regulation. Specifically, the relationship among coronary myoplasmic Ca2+, phosphorylation of MLC, and lumen diameter was examined with the use of an in vitro coronary microvessel model.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Experimental Techniques

Isolated arteriole preparations. Male Sprague-Dawley rats (250-350 g) were anesthetized with chloroform. Heparin sodium (1,000 IU/kg) was then administered intravenously. The heart was removed into cold (4°C) Krebs physiological saline solution (Krebs-PSS), which consisted of the following ionic concentrations (in mM): 119.0 NaCl, 25.0 NaHCO3, 5.0 KCl, 1.2 NaH2PO4, 1.2 MgSO4, 1.8 CaCl2, and 11.0 glucose. Immediately, coronary arterioles (100-260 µm in diameter) were dissected from the left anterior descending artery-dependent subepicardial region in the left ventricle with the use of a ×10-60 dissecting microscope (Olympus Optical, Tokyo, Japan). During dissection, care was taken to remove as much of the surrounding myocardium as possible, and the endothelium was intentionally preserved to maintain the vascular integrity. Vessels were transferred to an experimental chamber in which both ends of the microvessel were cannulated with dual glass micropipettes (tip interior diameter ~60 µm) and secured with 10-0 nylon monofilament suture (Ethicon, Somerville, NJ). The chamber was mounted on a transillumination system, and oxygenated (95% O2-5% CO2) Krebs-PSS (37°C) was continuously circulated through the vessel chamber. All of the animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals published by the National Research Council.

Measurements of intraluminal diameter. The vessels were pressurized to 40 mmHg in a no-flow state with the use of a burette manometer filled with Krebs-PSS. The internal luminal diameter was measured with a microscopic image system (Zeiss IM35 and Hitachi CCD TV camera, model KP-115). The calibration of the measurement was performed by use of an 80-µm tungsten wire. The changes in internal luminal diameter were expressed as percent contraction of the baseline diameter.

Measurements of [Ca2+]i. [Ca2+]i of coronary smooth muscle was measured by the method described by Meininger et al. (9), an approach we have previously used (8, 23). Coronary arterioles in the vessel chamber were loaded with 5 µM fura 2-AM (acetoxymethyl ester of fura 2) in Krebs-PSS containing 0.05% DMSO and 0.01% pluronic F-127. In the preliminary experiments, we confirmed that these loading vehicles do not affect the coronary microvascular reactivity. The loading time was 45 min at room temperature (21-23°C) followed by a 30-min wash period at 37°C. The objective lens used was a Nikon Fluor ×20 (numerical aperture 0.75). Optimal focus was adjusted by the viewing of smooth muscle layer under bright-field microscopy. Excitation light at 350 ± 5 and 390 ± 6 nm was used. Emission at 510 ± 24 nm was monitored with a photomultiplier tube (Hamamatsu R928), digitized by a data acquisition analog-to-digital converter, and processed by use of DTVee version 3.0 (Data Translation). [Ca2+]i was estimated from the ratio (R) of measured fluorescence signals (F) elicited at two wavelengths according to the following equation: R =[F350(mv) - F350(bg)]/[F390(mv) - F390(bg)], where F350(mv) and F390(mv) are the total measured fluorescence of the vessels at wavelengths of 350 and 390 nm, respectively, and F350(bg) and F390(bg) are the background fluorescence signals at each respective wavelength. Background signals were measured on vessels before the loading of fura 2-AM. In the preliminary experiments, the background autofluorescence intensities measured in the absence of fura 2 were not significantly altered by any of our experimental interventions, including administration of drugs and hypoxia. Despite the undoubted benefit of fura 2 in evaluating relative changes in [Ca2+]i, it has become clear that there are a number of uncertainties in precise quantification of absolute [Ca2+]i (2), and its dissociation constant (Kd) value is temperature sensitive (17). Therefore, we used the ratio of measured fluorescence signals elicited at wavelengths of 350 and 390 nm (R350/390) as an index of [Ca2+]i. As is well known, a ratiometric analysis of fura 2 is not linear to the absolute [Ca2+]i; however, this makes it possible to evaluate relative changes in [Ca2+]i independently of dye concentration, path length, excitation intensity, and photobleaching. Thus the ratios as presented would appear to be a reasonable index of the [Ca2+]i.

Measurements of MLC phosphorylation. Phosphorylation of 20-kDa MLC was measured by the method using glycerol-urea minigels (22). At specific time points during the experimental protocol, the vessels were rapidly removed from the experimental apparatus and immediately frozen (within 3 s) by immersion for 60 min in an acetone dry-ice slurry containing 10% TCA and 10 mM dithiothreitol (DTT). Frozen vessels were gradually warmed up to room temperature, followed by three rinses with acetone containing 5 mM DTT to remove TCA, and then stored at -80°C before use. In general, pooled segments of three vessels (6-8 mm in total length) subjected to a given protocol were combined for one phosphorylation measurement. The samples were suspended in 20 µl of urea sample buffer [8.0 M urea, 20 mM Tris base, 23 mM glycine (pH 8.6), 10 mM DTT, 10% glycerol, and 0.04% bromphenol blue], applied to glycerol-urea minigels (10% acrylamide-0.8% bisacrylamide, 40% glycerol, 20 mM Tris base, and 23 mM glycine), and subjected to electrophoresis at a constant voltage of 400 V until the dye front ran off. Electrophoretic transfer of proteins from the gels onto polyvinylidene difluoride membranes was carried out. The membrane was blocked in 5% milk solution for 30 min and then incubated overnight with a 20-kDa MLC antibody (Sigma). We preliminarily confirmed that this monoclonal antibody could not show any reactivity to myocardial tissue in the absence of coronary vessels. The blot was then placed in an anti-mouse IgG (goat) conjugated with horseradish peroxidase (Calbiochem) and visualized with chemiluminescence (Super Signal; Pierce, Rockford, IL). The MLC bands were quantitated densitometrically with the use of NIH Image, and the MLC phosphorylation levels were expressed as the area of phosphorylated MLC divided by the total area of 20-kDa MLC times 100%. Care was taken to ensure that bands subjected to densitometry were not saturated.

Experimental Design

In an attempt to simulate the clinically relevant condition with nonoxygenated hypothermic crystalloid hyperkalemic cardioplegia in the operating room, an in vitro microvessel model was designed. Normal Krebs solution was maintained within the vessels during exposure to cardioplegia. All cardioplegic solutions were applied into the vessel chamber. To confirm that vasoactive agent administered extraluminally has a direct effect on the endothelium smooth muscle interactions of isolated coronary microvessels, we preliminarily performed vascular function studies. Microvessels (100-180 µm in diameter, n = 6 in each group) were divided into two groups according to the drug administration routes: 1) extraluminal alone and 2) both intraluminal and extraluminal. All vessels were studied in a pressurized (40 mmHg), static (no-flow), normothermic (37°C) state. After baseline diameter measurements were taken, a stable thromboxane A2 analog U-46619 (10-7 M), which is a receptor-mediated direct smooth muscle constrictor, was applied by each route. The contractile responses to U-46619 measured after stabilization (generally 5-10 min) were 32.5 ± 3.1 and 31.1 ± 4.2%, respectively (%contraction of baseline diameter, P > 0.05 between groups). An endothelium-dependent vasodilator, ADP (10-4 M), was then coadministered with U-46619 by each route. ADP effectively reduced these U-46619-elicited contractions to 7.3 ± 3.0 and 5.1 ± 2.1%, respectively (%contraction of baseline diameter, P > 0.05 between groups). These findings indicated that extraluminally administered vasoactive agents can act on both endothelium and smooth muscle across the microvascular wall. On the basis of this observation, we regarded this model as a physiologically relevant preparation and used it in subsequent experiments.

Experimental Protocols

After baseline measurements of [Ca2+]i and internal luminal diameter were taken, vessels were subjected to 60-min hypoxic, hypothermic (20°C) high-K+ (K+ = 25 mM) cardioplegic solutions and then reperfused with oxygenated Krebs-PSS (37°C) for 60 min. The composition of the K+ cardioplegic solution was (in mM) 121.0 NaCl, 25.0 KCl, 12.0 NaHCO3, 1.2 CaCl2, and 11.1 glucose, equilibrated with 95% N2-5% CO2. The partial pressure of oxygen (PO2) was <40 mmHg, which was measured in pilot experiments by a blood gas analyzer (Instrumentation Laboratory, Lexington, MA). A true anoxic condition was not achieved because a small amount of oxygen continuously diffused into the solutions from the atmosphere. Temperature of the solutions was controlled with the use of a heat exchanger through the water jacket of the circuit and monitored with a thermistor probe set in the vessel chamber (Yellow Springs Instruments, Yellow Springs, OH).

Initially, the time course of changes in myoplasmic [Ca2+]i, MLC phosphorylation, and vascular diameter during cardioplegia/reperfusion was examined. On the basis of the results, eight groups were studied. Vessels in group I (control group) were subjected to the K+ cardioplegia supplemented with vehicle (DMSO) alone. For assessment of the dose responsiveness to pinacidil (Pin), vessels in groups II, III, and IV were supplemented with 10, 50, and 200 µM Pin into the K+ cardioplegia, respectively. To determine whether the endothelium-derived nitric oxide (NO) was involved in the Pin-induced vasomotor changes, in group V an NO synthase inhibitor, Nomega -nitro-L-arginine methyl ester (L-NAME; 10 µM), was coadministered with 200 µM Pin. To investigate the cellular mechanisms of Pin supplementation, in group VI an ATP-sensitive K+ (KATP) channel blocker glibenclamide (Glib; 10 µM) was coadministered with 200 µM Pin. Group IV served as the internal control for groups V and VI. To further investigate the coronary vasomotor regulation during K+ cardioplegia, we examined the effects of Glib alone (10 µM) in group VII and the administration of a voltage-dependent L-type Ca2+-channel blocker nicardipine (Nic; 10 µM) in group VIII.

Drugs

Chemicals were obtained from the following sources. Fura 2-AM and pluronic F-127 were from Molecular Probes (Eugene, OR); Pin, Glib, L-NAME, and Nic were from Sigma Chemical (St. Louis, MO). Pin and Glib were dissolved in DMSO. Nic was dissolved in 100% ethanol. The final concentration (<0.1%) of the solvents had no effect on the rat coronary microvessels.

Data Analysis

The responses of coronary vessels to only one protocol were examined once in each vessel. Six vessels were studied for the simultaneous [Ca2+]i diameter measurements in each group, and separate vessels not loaded with fura 2 were prepared for the MLC phosphorylation. Results were expressed as means ± SE. ANOVA combined with a multiple comparison Fisher's test was used to test the differences among groups with different interventions (Abacus Concepts, Berkeley, CA). The probability was considered to be significant at P < 0.05.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Time-Course Studies

First, we sought to clarify the time-course changes in the coronary myoplasmic [Ca2+]i, MLC phosphorylation, and vascular diameter in the control and 200 µM Pin-supplemented groups as a reference of this model for subsequent experiments. As shown in Fig. 1A, [Ca2+]i in the control group increased gradually in a time-dependent manner, reached a peak at 30 min, and maintained the peak value through the end point of a 60-min cardioplegic period. It returned to the baseline value after reperfusion. As shown in Fig. 1B, the phosphorylation levels of MLC in the control group rapidly increased, reached the peak at 3 min, and thereafter decreased but remained at suprabasal levels during the cardioplegic period. The time-course dynamics of the [Ca2+]i and MLC phosphorylation in the 200 µM Pin group were similar to those of the control group, but Pin significantly decreased the sustained levels of these two indexes during the cardioplegic period. As depicted in Fig. 1C, at the start of the hypothermic cardioplegic period, control vessels showed a transient relaxation that was followed by a gradual contraction; Pin vessels maintained the initial relaxation.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 1.   Time-course profiles of coronary smooth muscle intracellular calcium concentration ([Ca2+]i) (A), myosin light chain (MLC) phosphorylation (B), and lumen diameter (C) during and after 60 min of K+ cardioplegic solutions in vehicle alone (control) and in groups supplemented with 200 µM pinacidil (Pin200). Internal vessel diameter and [Ca2+]i (loaded with fura 2) were simultaneously monitored with microscopic image analysis (n = 6 vessels for each group). Changes in lumen diameter were expressed as percent contraction of baseline diameter. [Ca2+]i was expressed as the ratio of measured fluorescence signals elicited at 350 and 390 nm (R350/390). Phosphorylation of 20-kDa MLC was measured in pooled vessels by glycerol-urea gels and expressed as percentage of area of phosphorylated MLC over total area of MLC (n = 4-7 measurements at each time point). B, top: representative immunoblots for MLC (U, unphosphorylated; P, phosphorylated). Values are means ± SE. * P < 0.05 vs. control.

Dose Dependency of Pin

On the basis of the observations described above, in subsequent studies we focused on the responses at the end of the 60-min cardioplegic period. The data are summarized in Fig. 2. Pin supplementation at concentrations of 10, 50, and 200 µM significantly decreased the myoplasmic Ca2+ accumulation in a dose-dependent manner. Pin at 50 or 200 µM significantly decreased the level of MLC phosphorylation (both P < 0.05 vs. control) and consequently inhibited the cardioplegia-induced contraction (both P < 0.05 vs. control). Nic (10 µM) produced findings similar to those of >= 50 µM Pin.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of pinacidil (Pin) supplementation on coronary smooth muscle [Ca2+]i (A), MLC phosphorylation (B), and lumen diameter (C) at end of 60 min of K+ cardioplegic period. Control, vehicle alone; Pin10, Pin50, and Pin200, groups supplemented with 10 µM Pin, 50 µM Pin, and 200 µM Pin, respectively; Pin200+L-NAME, 200 µM Pin + 10 µM Nomega -nitro-L-arginine methyl ester (L-NAME); Pin200+Glib, 200 µM Pin + 10 µM glibenclamide (Glib); Glib, 10 µM Glib alone; Nic, 10 µM nicardipine (Nic). As described in Fig. 1, changes in [Ca2+]i (A) and vessel diameter (C) were simultaneously measured (n = 6 vessels for each group), and MLC phosphorylation level (B) was determined in pooled vessels (n = 4-6 measurements for each group). Each bar represents mean ± SE. * P < 0.05 vs. control. # P < 0.05 vs. Pin200.

Antagonism by Glib

Coadministration of a specific KATP channel blocker Glib (10 µM) with Pin (200 µM) significantly blocked those effects of Pin supplementation (all indexes P < 0.05 vs. 200 µM Pin group), suggesting that KATP channels are involved in the mechanism(s) mediating the vasodilative action of Pin.

Minimal Effect of L-NAME

Coadministration of an NO synthase inhibitor, L-NAME (10 µ M), with Pin (200 µM) did not make any significant changes on the [Ca2+]i, the MLC phosphorylation, or the relaxation observed in the 200 µM Pin group (all indexes P > 0.05 vs. 200 µM Pin group), indicating that, in this setting, the contribution of the endothelium-derived NO to the Pin-evoked relaxation is minimal.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The major findings of the present study were that 1) K+ cardioplegia-induced coronary constriction is associated with an elevation of [Ca2+]i and an increase in the level of MLC phosphorylation; 2) this potentiation of the Ca2+-MLC phosphorylation pathway was inhibited by supplementation of Pin in a dose-dependent manner; 3) a selective blocker of KATP channel, Glib, antagonized the effects of Pin; 4) the ability of Pin to attenuate the Ca2+-MLC phosphorylation cascade was noted, regardless of the activity of NO synthase; and 5) Nic produced findings similar to those of Pin.

Alteration of the Ca2+-MLC Phosphorylation Pathway in Coronary Arterioles

It is generally accepted that the major determinant of vascular smooth muscle contractility is the increase in [Ca2+]i via sarcolemmal channels or sarcoplasmic reticulum, which binds calmodulin and subsequently increases MLC kinase activity and phosphorylation of the 20-kDa regulatory MLC (3, 10, 19, 25). MLC phosphorylation results in an increased actomyosin Mg2+-ATPase activity and provides the chemical energy for force production under a variety of stimulus conditions (15). The present results provided experimental evidence that K+ cardioplegia activates this Ca2+-MLC phosphorylation pathway and causes vascular contraction.

Several factors probably modulate the coronary myoplasmic Ca2+ regulation during hypothermic K+ cardioplegia. It has been suggested that extracellular high K+-induced membrane depolarization promotes Ca2+ influx through voltage-operated Ca2+ channels, which can also lead to the release of Ca2+ from intracellular Ca2+ stores (1). In fact, in the present study, we demonstrated the potential role of the voltage-operated Ca2+ channels in the response to K+ cardioplegia using Nic, a selective L-type Ca2+ channel blocker. In addition, during surgical cardioplegia, especially nonoxygenated crystalloid cardioplegia, the coronary smooth muscle is exposed to conditions of insufficient oxygen supply, with a lower production of ATP compared with a normal state. It is widely recognized that hypoxia causes [Ca2+]i elevation in various cell types. A detailed discussion of the mechanism of hypoxia-related Ca2+ accumulation is beyond this brief review, but several intracellular organelles that have ATP-regulated Ca2+-handling mechanisms, i.e., the sarcoplasmic reticulum and mitochondria, may be considered as candidates for the Ca2+ release (3). Moreover, a number of thermosensitive Ca2+ transport systems may be modified in a hypothermic condition (11, 20, 24). We previously evaluated the individual effects of extracellular K+ concentration and temperature on the intracellular Ca2+ homeostasis during cardioplegia by use of this model (23). We observed that high-K+ concentration (25 mM) itself caused a marked increase in [Ca2+]i, and this high K+-induced intracellular Ca2+ accumulation was attenuated in Ca2+-free hypothermia (4°C) but was minimally affected in hypothermia in the presence of extracellular Ca2+ (1 mM). Thus the net effects of cold K+ cardioplegia on the intracellular Ca2+ regulation seem to be complex and interactive and need to be clarified in further studies.

Exposure to the K+ cardioplegia resulted in a transient elevation of MLC phosphorylation levels, which remained at significantly suprabasal levels during the 60-min cardioplegic period. This pattern of MLC phosphorylation is similar to that previously reported in swine carotid arteriolar smooth muscle with high-K+ stimulation (14), which might be consistent with the muscle entering the "latch" state, a condition whereby force generation is maintained by attached, slowly cycling cross bridges (15). The lower, but sustained, phosphorylation level during cardioplegia might be explained by the fact that the increase in [Ca2+]i is maintained and will continue to increase the MLC kinase activity relative to phosphatase activity (22).

Effects of Pin Supplementation on the Vasomotor Regulation

Pin effectively prevented the cardioplegia-induced Ca2+ accumulation in a dose-dependent manner at concentrations between 10 and 200 µM. Furthermore, at concentrations >50 µM, Pin attenuated the MLC phosphorylation, which resulted in prevention of the cardioplegia-induced vasoconstriction. K+ channels are known to be important in regulating the membrane potential of arterial smooth muscle (12, 13). Although we have not examined the membrane potential of vascular smooth muscle, the present findings are consistent with the previous report that opening of K+ channels shifts the resting membrane potential of vascular smooth muscle to the negative direction (hyperpolarization), leading to suppression of the inward Ca2+ current through voltage-operated Ca2+ channels and subsequently to vasorelaxation.

In line with the membrane potential-regulated influences on the Ca2+ influx, it has been reported that membrane hyperpolarization induced by a K+ channel opener, cromakalim, inhibits not only the sarcolemmal Ca2+ influx but also the inositol 1,4,5-trisphosphate-induced Ca2+ release from sarcoplasmic reticulum in porcine coronary artery (26). In addition, there is also a report that demonstrated that a K+ channel opener, nicorandil, directly stimulated the synthesis of cGMP in vascular smooth muscle, which consequently reduces [Ca2+]i because of acceleration of Ca2+ extrusion via the sarcolemmal Ca2+ pump, and may prevent the MLC phosphorylation (21). Thus several mechanisms may underlie the effect of K+ channel openers on preventing the cardioplegia-induced potentiation of the Ca2+-MLC phosphorylation pathway.

Inhibitory Effects of Glib

To provide a perspective for the mechanistic role of KATP channels on the cardioplegia-related vascular events, an inhibitory effect of Glib, a selective antagonist of KATP channels (12, 13), was addressed. As expected, the present study showed that Glib significantly antagonized the effects of Pin on the Ca2+-MLC phosphorylation cascade. Therefore, it is reasonable to assume that KATP channels are involved in the mechanisms mediating the effects of Pin on this signal transduction. These in vitro findings are consistent with a previous in vivo study with dogs that demonstrated that a Pin-evoked increase in the coronary blood flow was reversed by Glib (5). Furthermore, we tested the effects of Glib in the absence of Pin. The lack of effect of Glib alone on the K+ cardioplegia-induced potentiation of the Ca2+-MLC phosphorylation pathway suggests that KATP channels are not efficiently activated in the absence of a KATP channel-opening drug during cardioplegia.

Role of Endothelium-Derived NO

The effect of K+ cardioplegia on the endothelial function has been an unresolved topic. We have previously observed that an endothelium-dependent coronary vasorelaxation is markedly impaired after exposure to K+ cardioplegia (16). Therefore, it would be tempting to speculate that sufficient Pin supplementation could afford endothelial protection. In the present study, we tested whether the vasodilative effect of Pin was mainly mediated through the endothelium-derived NO (EDNO) mechanism. Interestingly, there was no significant effect on the vasodilative responses to Pin in the presence of the NO synthase inhibitor L-NAME compared with those in the absence of L-NAME. Thus our experiments suggest that the action of Pin is not mediated through the EDNO pathway in this setting. However, the endothelium-dependent relaxation and contraction are known to be attributable to a variety of different factors, including not only EDNO but also vasodilative and vasoconstrictive metabolites of arachidonic acid and endothelium-derived hyperpolarizing factor(s), and the nature of these factors has not yet been conclusively identified. Therefore, the possibility still remains that sufficient Pin supplementation could afford endothelial protection. Because the main purpose of this study was not to provide direct evidence about functional implications of the endothelium but to identify the overall effects of Pin supplementation on the vasomotor regulation in the integrated coronary microvasculature, we did not examined the effects of Pin on endothelium-denuded coronary vessels. Thus the coronary endothelium smooth muscle interactions under K+ cardioplegia remain to be elucidated.

Clinical Implications and Limitations

The state of myocardial perfusion is mainly regulated by the coronary microvascular tone. The present study was designed to elucidate the mechanisms for the functional alterations in coronary smooth muscle undergoing hypothermic K+ cardioplegia. The findings presented in this model provide some novel information to better understand the cellular mechanisms of cardioplegia-related functional changes in the coronary vasculature and fill the gap between the studies on the perfused heart preparations and those on the isolated vascular rings. In addition, the current study may further support a therapeutic approach for cardiac surgery with the K+ channel opener Pin to improve coronary vasoprotection.

We acknowledge the potential limitation inherent in our in vitro microvascular model, which is isolated from blood, neural activity, and hormonal influences. It is possible that the effect of Pin on the coronary Ca2+-MLC phosphorylation pathway may be different from warm or tepid cardioplegic solutions, because temperature substantially modulates ion-channel activity, membrane ATPases, and the activity of a number of enzymes regulating contractile protein interactions (24).

In conclusion, this study clarified that K+ cardioplegia augments the Ca2+-MLC pathway in coronary smooth muscle and results in vasoconstriction. Supplementation of >50 µM Pin effectively reduces the intracellular Ca2+ accumulation and maintains adequate vasorelaxation during the cardioplegic period through a KATP channel mechanism.


    ACKNOWLEDGEMENTS

We express gratitude to Dr. Inkyeom Kim (Signal Transduction Group in Boston Biomedical Research Institute) for generous guidance in MLC phosphorylation and Prof. Shigetsugu Ohgi (Tottori, Japan) for continuous encouragement.


    FOOTNOTES

This study was supported by National Heart, Lung, and Blood Institute Grants HL-46716 (to F. W. Sellke) and HL-31704 (to K. G. Morgan).

Address for reprint requests and other correspondence: F. W. Sellke, Div. of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center, 110 Francis St., LMOB Suite 2A, Boston, MA 02215 (E-mail:fsellke{at}caregroup.harvard.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 29 July 1999; accepted in final form 22 March 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Fabiato, A. Simulated calcium current can both cause calcium loading in and trigger the calcium release from the sarcoplasmic reticulum of a skinned canine cardiac cell. J Gen Physiol 85: 291-320, 1985[Abstract/Free Full Text].

2.   Grynkiewicz, G, Poenie M, and Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescent properties. J Biol Chem 260: 3440-3450, 1985[Abstract/Free Full Text].

3.   Horowitz, A, Menice CB, Laporte R, and Morgan KG. Mechanisms of smooth muscle contraction. Physiol Rev 76: 967-1003, 1996[Abstract/Free Full Text].

4.   Hosoda, H, Sunamori M, and Suzuki A. Effect of pinacidil on rat hearts undergoing hypothermic cardioplegia. Ann Thorac Surg 58: 1631-1636, 1994[Abstract].

5.   Katsuda, Y, Egashira K, Ueno H, Akatsuka Y, Narishige T, Arai Y, Takayanagi T, Shimokawa H, and Takeshita A. Glibenclamide, a selective inhibitor of ATP-sensitive K+ channels, attenuates metabolic coronary vasodilatation induced by pacing tachycardia in dogs. Circulation 92: 511-517, 1995[Abstract/Free Full Text].

6.   Katsumata, N, Shimokawa H, Seto M, Kozoi T, Yamawaki T, Kuwata K, Egashira K, Ikegaki I, Asano T, Sasaki Y, and Takeshita A. Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta . Circulation 96: 4357-4363, 1997[Abstract/Free Full Text].

7.   López, JR, Jahangir R, Jahangir A, Shen WK, and Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: possible implication in cardioplegia. J Thorac Cardiovasc Surg 112: 820-831, 1996[Abstract/Free Full Text].

8.   Matsuda, N, Tofukuji M, Morgan KG, and Sellke FW. Coronary microvascular protection with Mg2+: effects on intracellular calcium regulation and vascular function. Am J Physiol Heart Circ Physiol 276: H1124-H1130, 1999[Abstract/Free Full Text].

9.   Meininger, GA, Zawieja DC, Falcone JC, Hill MA, and Davey JP. Calcium measurement in isolated arterioles during myogenic and agonist stimulation. Am J Physiol Heart Circ Physiol 261: H950-H959, 1991[Abstract/Free Full Text].

10.   Murphy, RA. What is special about smooth muscle? The significance of covalent crossbridge regulation. FASEB J 8: 311-318, 1994[Abstract].

11.   Mustafa, SM, Pilcher CW, and Williams KI. Cooling-induced bronchoconstriction: the role of ion pumps and ion-carrier systems. Pharmacol Res 39: 125-136, 1999[ISI][Medline].

12.   Nelson, MT, and Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol Cell Physiol 268: C799-C822, 1995[Abstract/Free Full Text].

13.   Quayle, JM, Nelson MT, and Standen NB. ATP-sensitive and inward rectifying potassium channels in smooth muscle. Physiol Rev 77: 1165-1232, 1997[Abstract/Free Full Text].

14.   Rembold, CM, and Murphy RA. Myoplasmic calcium, myosin phosphorylation, and regulation of the crossbridge cycle in swine arterial smooth muscle. Circ Res 58: 803-815, 1986[Abstract/Free Full Text].

15.   Rembold, CM, and Murphy RA. Myoplasmic [Ca2+] determines myosin phosphorylation in agonist-stimulated swine arterial smooth muscle. Circ Res 63: 573-603, 1988.

16.   Sellke, FW, Shafique T, Schoen EJ, and Weintraub RM. Impaired endothelium-dependent coronary microvascular relaxation following cold potassium cardioplegia and reperfusion. J Thorac Cardiovasc Surg 105: 52-58, 1993[Abstract].

17.   Shuttleworth, TJ, and Thompson JL. Effect of temperature on receptor-activated changes in [Ca2+]i and their determination using fluorescent probes. J Biol Chem 266: 1410-1414, 1991[Abstract/Free Full Text].

18.   Skarvan, K, Graedel E, Hasse J, Stulz P, and Pfisterer M. Coronary artery spasms after coronary artery bypass surgery. Anesthesiology 61: 323-327, 1984[ISI][Medline].

19.   Somlyo, AP, and Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 372: 231-236, 1994[Medline].

20.   Speziali, G, Russo P, Davis DA, and Wagerle LC. Hypothermia enhances contractility in cerebral arteries of newborn lambs. J Surg Res 57: 80-84, 1994[ISI][Medline].

21.   Sumimoto, K, Domae M, Yamanaka K, Nakao K, Hashimoto T, Kitamura K, and Kuriyama H. Action of nicorandil on vascular smooth muscle. J Cardiovasc Pharmacol 10: S66-S75, 1987.

22.   Taylor, DA, Bowman BF, and Stull JT. Cytoplasmic Ca2+ is a primary determinant for myosin phosphorylation in smooth muscle cells. J Biol Chem 264: 6207-6213, 1989[Abstract/Free Full Text].

23.   Tofukuji, M, Matsuda N, Dessy C, Morgan KG, and Sellke FW. Intracellular free calcium accumulation in ferret vascular smooth muscle during crystalloid and blood cardioplegic infusions. J Thorac Cardiovasc Surg 118: 163-172, 1999[Abstract/Free Full Text].

24.   Vanhoutte, PM. Physical factors of regulation. In: Handbook of Physiology. The Cardiovascular System. Vascular Smooth Muscle. Bethesda, MD: Am. Physiol. Soc, 1980, sect. 2, vol. II, chapt. 16, p. 443-474.

25.   Walsh, MP. Regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 72: 919-936, 1994[ISI][Medline].

26.   Yamagishi, T, Yanagisawa T, and Taira N. Activation of phospholipase C by the agonist U46619 is inhibited by cromakalim-induced hyperpolarization in porcine coronary artery. Biochem Biophys Res Commun 187: 1517-1522, 1992[ISI][Medline].


Am J Physiol Heart Circ Physiol 279(3):H882-H888
0363-6135/00 $5.00 Copyright © 2000 the American Physiological Society



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. D. Diodato, N. R. Shah, S. M. Prasad, S. L. Gaynor, J. S. Lawton, and R. J. Damiano Jr
Donor heart preservation with pinacidil: the role of the mitochondrial KATP channel
Ann. Thorac. Surg., August 1, 2004; 78(2): 620 - 627.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsuda, N.
Right arrow Articles by Sellke, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsuda, N.
Right arrow Articles by Sellke, F. W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online